BiondVax's Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo Study
Stock Information for Scinai Immunotherapeutics Ltd Sponsed ADR (New)
Loading
Please wait while we load your information from QuoteMedia.